ResearcherGifu Municipal HospitalActive in the last 2 years

Eiichi Tomita

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2836-0414; OpenAlex author ID A5071769151. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2024: 1 paper

Papers 1

A phase-I study of second-line S-IROX for unresectable pancreatic cancer after gemcitabine plus nab-paclitaxel failure. Last author DOI 10.1007/s12032-024-02438-x ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Mitsuru Okuno · 1 shared paper, 2024 · strength 0.21
- Paper A phase-I study of second-line S-IROX for unresectable pancreatic cancer after gemcitabine plus nab-paclitaxel failure. DOI 10.1007/s12032-024-02438-x ↗
Ryuichi Tezuka · 1 shared paper, 2024 · strength 0.21
- Paper A phase-I study of second-line S-IROX for unresectable pancreatic cancer after gemcitabine plus nab-paclitaxel failure. DOI 10.1007/s12032-024-02438-x ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.